Results 21 to 30 of about 57,649 (323)

The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial

Journal of Clinical Medicine, 2023
Introduction: Bacterial prostatitis (BP) is a common prostatic infection characterized by a bimodal distribution in young and older men, with a prevalence between 5–10% among all cases of prostatitis and a high impact on quality of life.
B. Barone, B. F. Mirto, Alfonso Falcone, F. del Giudice, Achille Aveta, L. Napolitano, D. del Biondo, M. Ferro, G. Busetto, C. Manfredi, D. Terracciano, R. Gambardella, S. Pandolfo, F. Trama, Ciro De Luca, Raffaele Martino, Federico Capone, Gaetano Giampaglia, E. Sicignano, O. Tătaru, G. Lucarelli, F. Crocetto   +21 more
semanticscholar   +1 more source

Extremely Elevated Prostate-Specific Antigen in Acute Prostatitis: A Case Report

Cureus, 2023
Elevated prostate-specific antigen (PSA) levels are mostly suggestive of prostate cancer, but they are elevated in non-cancerous prostatic conditions as well.
A. Nepal, Prabhat Sharma, Shristi Bhattarai, Zubin A. Mahajan, Akhya Sharma, A. Sapkota, Aviskar Sharma   +6 more
semanticscholar   +1 more source

Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis

Journal of Immunological Research, 2022
Purpose. Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common urological disorder. Although ferroptosis is closely associated with inflammation, oxidative stress, and neuropathic pain, its role in CP/CPPS has not yet been elucidated ...
Dongxu Lin, Mengyang Zhang, Changcheng Luo, Pengyu Wei, K. Cui, Zhong Chen   +5 more
semanticscholar   +1 more source

Oral Fosfomycin Formulation in Bacterial Prostatitis: New Role for an Old Molecule-Brief Literature Review and Clinical Considerations

Infectious Disease Reports, 2022
Bacterial prostatitis infections are described as infections that are difficult-to-treat, due to prostate anatomic characteristics along with clinical difficulty in terms of diagnosis and management. Furthermore, the emergence of multidrug resistant (MDR)
Andrea Marino, S. Stracquadanio, Carlo Maria Bellanca, Egle Augello, Manuela Ceccarelli, G. Cantarella, R. Bernardini, G. Nunnari, B. Cacopardo   +8 more
semanticscholar   +1 more source

Prevalence of and risk factors for asymptomatic inflammatory (NIH-IV) prostatitis in Chinese men. [PDF]

PLoS ONE, 2013
BACKGROUND: While many investigators have studied symptomatic prostatitis, little research has been done with regard to asymptomatic (NIH-IV) prostatitis.
Chunlei Wu, Zhifu Zhang, Zheng Lu, Ming Liao, Youjie Zhang, Yuanliang Xie, Xuefeng Guo, Xiaoxiang Yu, Xiaobo Yang, Yong Gao, Aihua Tan, Zengnan Mo   +11 more
doaj   +1 more source

The human gastrointestinal microbiota and prostate cancer development and treatment [PDF]

, 2020
The human gastrointestinal microbiome contains commensal bacteria and other microbiota that have been gaining increasing attention in the context of cancer development and response to treatment.
Alanee, Alexander, Althuis, Amirian, Arthur, Bostwick, Boursi, Buti, Cheng, Cimadamore, Cockburn, Costello, Cuevas-Ramos, Daniels, De Marzo, De Marzo, Dennis, Dominguez-Bello, Eckburg, Elkahwaji, Elkrief, Figueiredo, Gill, Golombos, Goodman, Graessler, Haller, Hamada, Hatakeyama, Hunter, Iida, Kamps, Lampe, Lara-Tejero, Lenoir, Liss, Masood, Meldrum, Miquel, Miyake, Montassier, Mosca, Mouraviev, Musso, Nakai, O'Hara, Olsson, Paulos, Plottel, Porter, Poutahidis, Punnen, Qin, Redman, Ridlon, Roberts, Roy, Russell, Sfanos, Siegel, Smith, Sokol, Sokol, Sonn, The Global Cancer Observatory, Tulstrup, Vande Voorde, Viaud, Vivarelli, Vétizou, Wilson   +70 more
core   +1 more source

Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments

Frontiers in Pharmacology, 2021
Background: Chronic Bacterial Prostatitis (CBP) is an inflammatory condition caused by a persistent bacterial infection of the prostate gland and its surrounding areas in the male pelvic region. It is most common in men under 50 years of age.
Apurva Virmani Johri, P. Johri, N. Hoyle, Levan Pipia, L. Nadareishvili, D. Nizharadze   +5 more
semanticscholar   +1 more source

Liquid Chromatograph-Mass Spectrometry-Based Non-targeted Metabolomics Discovery of Potential Endogenous Biomarkers Associated With Prostatitis Rats to Reveal the Effects of Magnoflorine

Frontiers in Pharmacology, 2021
Magnoflorine (Mag) has multiple pharmacological activities for the prevention and treatment of prostatitis. However, its molecular mechanisms andpharmacological targets are not clear.
Yin Yuan, Fei-Xue Dong, Xu Liu, Hong-Bin Xiao, Zhong-Guang Zhou   +4 more
doaj   +1 more source

Pathogenic Roles of CXCL10 in Experimental Autoimmune Prostatitis by Modulating Macrophage Chemotaxis and Cytokine Secretion

Frontiers in Immunology, 2021
Chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS) is an inflammatory immune disease characterized by intraprostatic leukocyte infiltration and pelvic or perineal pain. Macrophages play vital roles in the pathogenesis of CP/CPPS. However, the
X. Hua, Shengdong Ge, Meng Zhang, Fan Mo, Li-Gang Zhang, Jiong Zhang, Cheng Yang, Sheng Tai, Xian-guo Chen, Li Zhang, C. Liang   +10 more
semanticscholar   +1 more source

Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) [PDF]

, 2013
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a complex condition for which the etiological determinants are still poorly defined. To better characterize the diagnostic and therapeutic profile of patients, an algorithm known as UPOINT was
Houbiers, J, Magri, V, Marras, E, Panagopoulos, P, Perletti, Gianpaolo, Petrikkos, GL, Van Till, JWO, Wagenlehner, FME   +7 more
core   +2 more sources